Clinical Trials Browser

Has results × Neoplasms × cabozantinib × Clear all

Carcinoma, Carcinoma, Hepatocellular, Neoplasms

NCT03937219 2025-09-10

COSMIC-313

Phase 3 Active not recruiting

855 enrolled 12 charts

Genitourinary

Carcinoma, Carcinoma, Renal Cell, Neoplasms

NCT00940225 2024-04-25

Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

Phase 2 Completed

730 enrolled 25 charts

BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT03542877 2022-07-15

Investigating Cabozantinib in Patients With Refractory Metastatic Colorectal Cancer

Phase 2 Completed

44 enrolled 19 charts

Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT01663272 2018-09-19

A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer

Phase 1 Completed

12 enrolled 6 charts

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT01428219 2017-12-12

Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone

Phase 2 Terminated

25 enrolled 12 charts

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

Clinical Trials

COSMIC-312

COSMIC-313

Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

Investigating Cabozantinib in Patients With Refractory Metastatic Colorectal Cancer

A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer

Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone